Document is current
Any future updates will be listed below
-
Authors
Arredondo, Marcial https://orcid.org/0000-0001-9612-7548
Mestanza, Ferran https://orcid.org/0009-0003-6740-2792
Carpio, Ruth https://orcid.org/0009-0003-4098-0373
Escarrabill, Joan https://orcid.org/0000-0003-0492-9645
López-Solà, Clara https://orcid.org/0000-0001-8104-5291
Palou, Eva
Acosta, Lesly
Fernández, Laia
Vilas-Riotorto, Vanesa
Sauri, Tamara https://orcid.org/0000-0002-7479-5120
Mellado, Begoña https://orcid.org/0000-0002-8088-5966
- License Information
-
More Information
Article History
Received: 15 November 2024
Accepted: 18 March 2025
First Online: 17 April 2025
Declarations
:
: Begoña Mellado has received research grants, funding, and honoraria for speaking engagements and travel accommodations from Astellas, Bayer, BMS, Ipsen, Janssen, Pfizer, Roche, and Sanofi. Laia Fernández has participated in the Speakers Bureau for IPSEN, received travel support from MSD, and has other affiliations with Merck. Tamara Sauri has received honoraria as a speaker from Bristol Myers Squibb (BMS), MSD, AstraZeneca, Astellas, and Jazz Pharmaceuticals. She has also served as a member of the Advisory Board for Amgen SA and Beigene Esp. SLU.
